AbbVie Options Trading Spikes

Unusual Options Activity in AbbVie Inc. (ABBV) Stock

A surge in unusual options activity has been observed in AbbVie Inc. (ABBV) stock, with traders betting big on the pharmaceutical giant's future price movements. According to Benzinga's proprietary data, the unusual activity was detected on April 25.

The unusual activity was centered around the April 2025 expiration date, with traders buying up large quantities of calls and puts. The most active strike price was the $90 mark, with over 13,000 contracts traded. This represents a significant increase in trading volume compared to the average daily volume of around 4,000 contracts.

The unusual activity in ABBV options suggests that traders are betting on a significant price move in the company's stock. Some traders may be looking to capitalize on the company's recent momentum, as ABBV has been a strong performer in recent months. Others may be looking to hedge against potential volatility in the company's stock price.

ABBV is a leading pharmaceutical company that develops and markets a range of treatments for various diseases, including immunology, oncology, and neuroscience. The company has a strong pipeline of new products, which could drive growth in the coming years.

The unusual options activity in ABBV stock is a sign that traders are taking notice of the company's potential for future growth. As the company continues to release new products and expand its pipeline, it will be interesting to see if this unusual activity translates into actual price movements in the company's stock.